BMJ Open· Balasubramaniam, G., Almond, M., Harnett, P., Turner, D., Scales, J., Zhang, J., Moore, C., Hayden, K., Roddy, E., Mallen, C., Stack, J., Bhagat, S., Ng, N., Rutherford, A., Dasgupta, B.·· 2026-09-30AI 评分30
ASGARD 试验:Anakinra 对比肌注醋酸甲泼尼龙治疗慢性肾病痛风急性发作的可行性研究
Anakinra versus intramuscular methylprednisolone acetate for gout flares in people with chronic kidney disease (ASGARD): a UK randomised multicentre, double-blind, double-dummy controlled feasibility study with economic, qualitative and safety assessment
AI 导读
ASGARD 双盲随机对照可行性试验对比了 Anakinra 与肌注醋酸甲泼尼龙治疗慢性肾病痛风急性发作的效果。该试验因入组不足未达整体成功标准,但满足程序可行性指标。研究收集了疼痛缓解时间、安全及卫生经济学数据以评估主要终点。
来源:BMJ Open · bmjopen.bmj.com